开窗-分支支架与内脏去分支联合支架(杂交)用于复杂主动脉瘤修复
回顾性分析2010至2015年98例需四血管重建的复杂主动脉瘤患者,77.5%接受开窗-分支支架(FBSG),22.4%接受杂交修复。FBSG组早期死亡率及肾衰竭、肠系膜缺血发生率低于杂交组,随访死亡率也较低。作者认为FBSG可能应作为有合并症复杂动脉瘤的首选,杂交修复可考虑用于不适合腔内修复的急性病例。
要点
- 30天死亡率为15.3%(15/98),杂交术式与更高早期死亡率独立相关(OR 6.3,P=0.01)。
- 杂交组急性肾衰竭(2.6% vs 18%,P=0.03)和肠系膜缺血(3% vs 23%,P=0.001)更常见。
- 平均随访16.4±5个月,FBSG组死亡率12% vs 杂交组45%(P=0.05)。
核心结论
- FBSG与杂交技术对于需四血管重建的复杂主动脉瘤似乎是可行的治疗选择。
- 与杂交手术相比,FBSG可能与更低的死亡率和并发症率相关。
- 作者认为,对于有合并症的复杂动脉瘤患者,FBSG应作为治疗选择;而对于不适合腔内修复的急性病例,应考虑杂交修复。
研究设计与样本
- 回顾性分析2010至2015年连续治疗的需四血管重建的复杂主动脉瘤患者临床资料,共98例(65例男性,68%),平均年龄70.65±4岁。
- 动脉瘤类型:Crawford I型12例、II型18例、III型12例、IV型24例、V型6例,近肾及肾上型26例。
- 治疗方式:FBSG 76/98(77.5%),杂交修复22/98(22.4%)。
- FBSG组使用15例成品多分支支架、3例术者改良开窗支架和58例定制装置;38例使用四个开窗、30例使用四个分支、8例使用开窗与分支组合。
- 杂交组中18/22(82%)采用两阶段手术,所有靶血管均通过88条旁路成功重建。
主要发现
- 共处理304根靶血管,技术成功率96%(292/304)。
- 30天死亡率为15.3%(15/98),早期靶血管闭塞率为9.1%(FBSG组2例,杂交组7例)。
- 多因素分析显示杂交术式与更高的早期死亡率独立相关(OR 6.3,P=0.01)。
- 并发症主要包括肺部并发症(16.3%)、下肢无力(16.3%)、肠系膜缺血(6.1%)、出院时透析(6.1%)和完全性截瘫(4.3%)。
- 杂交组急性肾衰竭(2.6% vs 18%,P=0.03)和肠系膜缺血(3% vs 23%,P=0.001)发生率更高。
关键数值与推荐
- 平均随访16.4±5个月,总死亡率为19.4%(FBSG组12% vs 杂交组45%,P=0.05)。
- 移植物和支架移植物通畅率为87.8%(3个分支和9条旁路闭塞)。
- 26例患者有症状(16例疼痛,10例包裹性破裂)。
- 平均最大动脉瘤直径65±15 mm,53%的患者有既往主动脉干预史。
临床怎么用
- 作者认为,对于有合并症的复杂动脉瘤患者,FBSG应作为治疗选择。
- 作者认为,对于不适合腔内修复的急性病例,应考虑杂交修复。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to assess the immediate postoperative and midterm outcome of complex aortic aneurysm treatment necessitating four-vessel revascularization with either a total endovascular approach (fenestrated-branched stent graft [FBSG]) or a hybrid technique of visceral debranching plus stenting. METHODS: The clinical data of consecutively treated patients presenting with a complex aortic aneurysm that necessitated four-vessel revascularization between 2010 and 2015 were retrospectively analyzed. RESULTS: There were 98 patients (65 men [68%]) with a mean age of 70.65 ± 4 years who presented with aortic aneurysm (Crawford type I, 12; type II, 18; type III, 12; type IV, 24; type V, 6; and juxtarenal and suprarenal, 26) and were treated with either FBSG (76/98 [77.5%]) or hybrid repair (22/98 [22.4%]). Twenty-six patients were symptomatic (16, pain; 10, contained rupture). The mean maximum aneurysm diameter was 65 ± 15 mm, and 53% of the patients had a prior aortic intervention. In FBSG-treated patients, 15 off-the-shelf multibranched stent grafts, 3 surgeon-modified fenestrated stent grafts, and 58 custom-made devices tailored to the patient's anatomy were used. Four fenestrations, four branches, and their combination were used in 38 cases, 30 cases, and 8 cases, respectively. A total of 304 target vessels were addressed, with technical success rate of 96% (292/304). In most hybrid cases (18/22 [82%]), a two-stage procedure was undertaken. All target vessels were successfully revascularized with 88 bypasses. The 30-day mortality was 15.3% (15/98), and the early target vessel occlusion was 9.1% (2 in FBSG, 7 in hybrid). After multivariate analysis, type of procedure (hybrid) was independently associated with higher early mortality (odds ratio, 6.3; P = .01). The morbidity was mainly attributed to pulmonary complications (16.3%), lower extremity weakness (16.3%), mesenteric ischemia (6.1%), dialysis on discharge (6.1%), and complete paraplegia (4.3%). Acute renal failure (2.6% vs 18%; P = .03) and mesenteric ischemia (3% vs 23%; P = .001) presented more commonly in the hybrid group. The mean follow-up was 16.4 ± 5 months, and the mortality rate was 19.4% (12% in the FBSG group vs 45% in the hybrid group; P = .05). The graft and stent graft patency rate was 87.8% (three branches and nine bypasses were occluded). CONCLUSIONS: FBSG and hybrid technique seem to be feasible treatment options for complex aortic aneurysms that necessitate four-vessel revascularization. FBSG may be associated with lower mortality and morbidity rates in comparison to the hybrid procedure. FBSG should be the treatment of choice for complex aneurysms in patients with comorbidities, whereas hybrid repair should be considered for acute cases unsuitable for endovascular repair.
引用
- Tsilimparis N, Debus SE, Biehl M, et al. Fenestrated-branched endografts and visceral debranching plus stenting (hybrid) for complex aortic aneurysm repair. J Vasc Surg. 2018. PMID: 29502996. doi:10.1016/j.jvs.2017.09.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。